Adherence to interferon β-1b treatment in patients with multiple sclerosis in Spain
about
Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple SclerosisEvaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort studyTreatment satisfaction, adherence and behavioral assessment in patients de-escalating from natalizumab to interferon βPatient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart® in patients with multiple sclerosis.RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence.Medication adherence among patients with chronic conditions in Italy.Adherence to fingolimod in multiple sclerosis: an investigator-initiated, prospective, observational, single-center cohort study.Health-related quality of life and disease-modifying treatment behaviour in relapsing-remitting multiple sclerosis--a multicentre cohort study.
P2860
Q28597830-5A6DB050-CB05-4358-9C7D-65A702F074B7Q34980458-588BE812-8AE8-4298-97D6-692555E740ABQ35103997-752E48BE-49CF-46DE-93F9-9764EF59CD41Q36698871-3C1D8468-45FF-4E01-9A24-DA986314DAE3Q37682836-75DA6434-38EE-4633-B709-04478F6F93F9Q38068514-15F5AAA9-E4EF-4178-9747-B922F600236BQ43679400-537B8A84-D0B3-4B7B-A6F6-12C385C58F1FQ44073784-7DE12A76-C98B-48E1-976F-A243EBCB51CEQ47928073-2C1734F7-54E7-4A13-B81F-5A48DB449155
P2860
Adherence to interferon β-1b treatment in patients with multiple sclerosis in Spain
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Adherence to interferon β-1b treatment in patients with multiple sclerosis in Spain
@ast
Adherence to interferon β-1b treatment in patients with multiple sclerosis in Spain
@en
Adherence to interferon β-1b treatment in patients with multiple sclerosis in Spain
@nl
type
label
Adherence to interferon β-1b treatment in patients with multiple sclerosis in Spain
@ast
Adherence to interferon β-1b treatment in patients with multiple sclerosis in Spain
@en
Adherence to interferon β-1b treatment in patients with multiple sclerosis in Spain
@nl
prefLabel
Adherence to interferon β-1b treatment in patients with multiple sclerosis in Spain
@ast
Adherence to interferon β-1b treatment in patients with multiple sclerosis in Spain
@en
Adherence to interferon β-1b treatment in patients with multiple sclerosis in Spain
@nl
P2093
P2860
P3181
P1433
P1476
Adherence to interferon β-1b treatment in patients with multiple sclerosis in Spain
@en
P2093
Eduardo Agüera
Guillermo Izquierdo
Javier Agüera
Javier Argente
Javier Millán-Pascual
Joaquin Argente
Jordi Farrés
Jorge Millán-Pascual
Jose Maria Errea
Jose Maria Soler
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0035600
P407
P577
2012-01-01T00:00:00Z